This article first appeared in Forum, The Edge Malaysia Weekly on August 31, 2026 - September 6, 2026
The opening of Selgate Specialist Hospital Rawang (SSHR) earlier this year is undoubtedly welcome news for residents in northern Selangor. Rapid population growth in Rawang, Sungai Buloh and surrounding areas has increased demand for healthcare services, making additional capacity both necessary and timely. The hospital’s emphasis on digital infrastructure, electronic medical records and integrated care systems also reflects the direction that modern healthcare delivery should be heading. From an infrastructure perspective, the investment deserves recognition.
Yet beyond the ribbon-cutting ceremonies and announcements of new facilities lies a more important question. Malaysia’s healthcare debate often focuses on the number of hospitals being built but rarely examines who owns them and what obligations come with that ownership. As state governments and government-linked entities become increasingly active participants in private healthcare, the conversation should extend beyond expansion itself and towards accountability, public value and long-term system sustainability.
The traditional narrative surrounding private healthcare investment is relatively straightforward. New hospitals create jobs, attract investment, improve patient access and stimulate economic activity. These benefits are real and should not be dismissed. However, healthcare differs from most other industries because its workforce, training ecosystem and service delivery are deeply intertwined with public institutions. Private healthcare growth does not occur in isolation. It relies heavily on foundations built and financed by the public sector over many decades.
One immediate concern is workforce availability. Malaysia continues to face shortages of specialists, nurses and experienced allied health professionals. While constructing a new hospital may take only a few years, developing a specialist often requires more than a decade of education, supervision and clinical training. The limiting factor is therefore not physical infrastructure but human capital. Expanding healthcare capacity without expanding the workforce raises legitimate questions about how new facilities will be staffed.
In practice, many healthcare workers recruited by private hospitals originate from the public sector. Specialists trained in government hospitals often transition into private practice after reaching professional maturity. While such movement is a normal feature of labour markets, it creates challenges when workforce growth fails to keep pace with healthcare expansion. Public hospitals lose experienced personnel while remaining staff absorb heavier workloads and increased service demands.
The consequences extend beyond workforce management. Government hospitals play multiple roles simultaneously. They provide clinical services, train future specialists, supervise junior doctors, conduct research and deliver healthcare to millions of Malaysians regardless of income level. When experienced personnel leave the public system, the impact is felt across all these functions. Waiting times may lengthen, institutional knowledge may be lost and pressure on remaining staff may intensify.
This reality becomes particularly relevant when public entities themselves become owners of private healthcare facilities. Selangor is not the only participant in this space. Across Malaysia, government-linked companies, state investment arms and public institutions have become increasingly involved in healthcare ventures. Such participation is not inherently problematic. In fact, public-sector involvement can bring long-term investment horizons, stronger governance structures and strategic alignment with national healthcare objectives.
However, public ownership introduces a different set of expectations. A purely private healthcare company is accountable primarily to its shareholders. A state-linked healthcare institution carries broader responsibilities because its ultimate stakeholders are citizens. The public therefore has a legitimate interest in understanding not only whether these ventures are commercially successful but also whether they contribute meaningfully to wider healthcare objectives.
This raises an important economic question. Public institutions bear much of the cost of producing healthcare professionals through publicly funded universities, specialist training programmes and government hospitals. Taxpayers effectively finance the development of the healthcare workforce over many years. When state-linked entities subsequently compete for the same talent within the private market, policymakers must consider whether sufficient mechanisms exist to ensure that public investment continues to generate public benefit.
The issue is not profitability. There is nothing inherently wrong with a state-owned healthcare venture generating strong financial returns. Sustainable businesses are better positioned to expand services, invest in technology and improve patient outcomes. The concern arises when profitability becomes the primary measure of success while broader public objectives receive less attention. Public ownership should create public value alongside commercial performance, not treat the two as mutually exclusive goals.
Greater transparency would help address this concern. Citizens should be able to understand how state-linked healthcare ventures perform financially and how those returns are utilised. Are profits being reinvested into healthcare capacity? Are they supporting workforce development? Are they strengthening public-private collaboration? These questions are particularly relevant because healthcare occupies a unique position at the intersection of public welfare and commercial activity.
One possible approach would be to establish formal reinvestment mechanisms linked to healthcare profits. A defined proportion of earnings generated by state-linked healthcare entities could be transparently allocated towards strengthening healthcare capacity within the state. Such initiatives might include specialist retention programmes, nursing scholarships, workforce welfare measures, facility upgrades, digital interoperability projects and postgraduate training support. Visible reinvestment would strengthen public confidence and demonstrate alignment with broader healthcare goals.
Equally important is the need to measure success differently. Traditional corporate metrics such as revenue growth, occupancy rates and profitability remain important indicators of organisational performance. However, state-linked healthcare institutions should also be evaluated against public outcomes. These could include healthcare workforce expansion, training opportunities created, specialist development programmes funded, access improvements achieved and collaborations established with public hospitals.
Future healthcare expansion should also be accompanied by stronger workforce planning. New hospitals should not merely redistribute existing healthcare workers from one institution to another. Instead, they should contribute to enlarging the overall talent pool through training investments, educational partnerships and programmes designed to attract Malaysian healthcare professionals currently working abroad. Sustainable growth requires net additions to workforce capacity rather than competition over a limited supply of talent.
Malaysia unquestionably needs additional healthcare infrastructure to meet the demands of an ageing population and growing healthcare expectations. The challenge is ensuring that expansion strengthens the entire healthcare ecosystem rather than creating unintended pressures elsewhere in the system. More hospitals alone do not automatically translate into better healthcare outcomes if workforce constraints and governance considerations remain unaddressed.
The opening of SSHR represents an important investment in the future of healthcare delivery in Selangor. Yet the larger policy discussion should not end with the construction of a new hospital. As public entities increasingly participate in private healthcare, Malaysians should ask a simple but important question: How can these ventures create both commercial success and public value? The answer will help determine whether healthcare expansion ultimately strengthens the nation’s healthcare system or merely redistributes its existing limitations.
Dr David Chang is a registered pharmacist and PhD graduate. Dr Sean Thum is a policy officer at the Ministry of Communications. Dr Wong Yen Jun is a lecturer at the School of Pharmacy, Monash University Malaysia. Dr Tharani Loganathan is an associate professor in the Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya.
Save by subscribing to us for your print and/or digital copy.
P/S: The Edge is also available on Apple's App Store and Android's Google Play.